This Webinar is Now Available On-Demand
Tackling Bioavailability Challenges for the
Next Generation of Small Molecules
Note: If you have already registered for this webinar, please click this link and use your email to login to the platform again
Event Details:
With small molecules continuing to make up the majority share of new drug approvals, the future is promising for oral drug development, and the innovation potential is significant. As new chemical modalities such as targeted protein degraders, covalent inhibitors, and RNA targeting small molecules, demonstrate the promise of clinical success, they also present new complexities in formulation and manufacturing requirements. As these new molecules continue to enable medical breakthroughs in therapeutic areas such as oncology, many require advanced formulation technologies to enhance bioavailability. Identifying the appropriate technology to overcome bioavailability challenges in early development is essential to avoiding expensive and lengthy development programs.
In this webinar, speakers share industry insights into small molecule drug development advancements and discuss innovative, scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.
In this webinar we cover these key points:
- Gain industry perspectives on the emerging classes of small molecules and their potential challenges for oral bioavailability
- Understand the key challenges and advantages of the most preferred formulation technologies
- Gain insight into how technology selection decisions made in early development can impact manufacturability
Featured Speakers:
Brent Moody
Director, Scientific Advisory
Catalent
By submitting this form you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement.